(Q77953405)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933433%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

Administration of intravenous immunoglobulin (IVIG) in vivo--down-regulatory effects on the IL-1 system (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933433%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

6

S S Frøland

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933433%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1

P Aukrust

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933433%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

F Müller

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933433%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

M Svenson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933433%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

I Nordøy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933433%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

K Bendtzen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933433%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933433%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

9 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933433%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933433%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933433%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

136-143

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933433%20AND%20SRC:MED&resulttype=core&format=json

Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: II. IL-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes

9 December 2019

cites work

1 reference

12 December 2020

Sandwich ELISA formats designed to detect 17 kDa IL-1 beta significantly underestimate 35 kDa IL-1 beta

1 reference

12 December 2020

Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features

1 reference

12 December 2020

Primary antibody deficiency in adults

1 reference

12 December 2020

Manipulating the Immune System with Immune Globulin

1 reference

12 December 2020

Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro

1 reference

12 December 2020

Human anti-interleukin 1 alpha antibodies

1 reference

12 December 2020

Impaired in vitro survival of monocytes from patients with HIV infection

1 reference

12 December 2020

Distribution and characterization of autoantibodies to interleukin 1 alpha in normal human sera

1 reference

12 December 2020

Rapid immunomagnetic phenotyping of cells.

1 reference

12 December 2020

Differential binding of human interleukin‐1 (IL‐1) receptor antagonist to natural and recombinant soluble and cellular IL‐1 type I receptors

1 reference

12 December 2020

Decreased levels of total and reduced glutathione in CD4+ lymphocytes in common variable immunodeficiency are associated with activation of the tumor necrosis factor system: possible immunopathogenic role of oxidative stress

1 reference

12 December 2020

Intravenous immunoglobulins in the therapy of autoimmune and systemic inflammatory disorders

1 reference

12 December 2020

Southwestern Internal Medicine Conference: high-dose intravenous gamma globulin therapy: how does it work?

1 reference

12 December 2020

Cytokines and natural regulators of cytokines

1 reference

12 December 2020

Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin)

1 reference

12 December 2020

Elevated serum levels of interleukin-4 and interleukin-6 in patients with common variable immunodeficiency (CVI) are associated with chronic immune activation and low numbers of CD4+ lymphocytes

1 reference

12 December 2020

Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo

1 reference

12 December 2020

Pooled human IgG modulates cytokine production in lymphocytes and monocytes.

1 reference

12 December 2020

Anti-cytokine nature of natural human immunoglobulin: one possible mechanism of the clinical effect of intravenous immunoglobulin therapy

1 reference

12 December 2020

IgG induction of IL-1 receptor antagonist production by human monocytes

1 reference

12 December 2020

Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.

1 reference

12 December 2020

Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses.

1 reference

12 December 2020

Interleukin 1 beta propeptide is detected intracellularly and extracellularly when human monocytes are stimulated with LPS in vitro

1 reference

12 December 2020

Specific binding of interleukin 1 (IL-1) beta and IL-1 receptor antagonist (IL-1ra) to human serum. High-affinity binding of IL-1ra to soluble IL-1 receptor type I

1 reference

12 December 2020

Binding of cytokines to pharmaceutically prepared human immunoglobulin

1 reference

12 December 2020

Measuring circulating cytokines

1 reference

12 December 2020

Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]

1 reference

12 December 2020

Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency--possible immunologic and clinical consequences

1 reference

12 December 2020

Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production

1 reference

12 December 2020

Biologic basis for interleukin-1 in disease

1 reference

12 December 2020

Immunomodulatory effect of immunoglobulins

1 reference

12 December 2020

Intravenous immune globulin therapy for neurologic diseases

1 reference

12 December 2020

Common variable immunodeficiency: how many diseases?

1 reference

12 December 2020

Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases

1 reference

12 December 2020

Increased in vivo antibody activity against interferon alpha, interleukin-1alpha, and interleukin-6 after high-dose Ig therapy

1 reference

12 December 2020

Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-alpha activity in human immunodeficiency virus type 1 infection

1 reference

12 December 2020

High-avidity autoantibodies to cytokines

1 reference

12 December 2020

10.1046/J.1365-2249.1999.00757.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933433%20AND%20SRC:MED&resulttype=core&format=json

release_ao6ygml4q5bt7hmlvf4fi6agvi

9 December 2019

Fatcat ID

0 references

PMC publication ID

1905185

0 references

1 reference